Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Oxidative Stress
2017 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe
2018 StandoutNobel
Imaging Mycobacterial Trehalose Glycolipids
2017 StandoutNobel
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso
2011
Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literature
2003
Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement
2014 Standout
Endemic Contamination of Clinical Specimens by Mycobacterium gordonae
2000
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Molecular mechanisms of antibiotic resistance
2014 Standout
Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era
2007
Characterization of the Catalase-Peroxidase Gene (katG) and inhA Locus in Isoniazid-Resistant and -Susceptible Strains of Mycobacterium tuberculosis by Automated DNA Sequencing: Restricted Array of Mutations Associated with Drug Resistance
1996
Mycobacterium genavense: An emerging pathogen
1994
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
2011
NONTUBERCULOUS MYCOBACTERIAL INFECTIONS
1997
Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis
1998
Why do bacteria use so many enzymes to scavenge hydrogen peroxide?
2012
A Comparison of Two Regimens for the Treatment ofMycobacterium aviumComplex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin
1996
Mycobacterium genavense sp. nov.
1993
IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, South India
1995
Leprosy
1999
Mycobacterium malmoense Infections in the United States, January 1993 through June 1995
1998
A method for rapid detection of rifampicin-resistant isolates ofMycobacterium leprae
2001
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
2005 Standout
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
2003
Inducible -Lactamases: Clinical and Epidemiologic Implications for Use of Newer Cephalosporins
1988
The therapeutic approach to non-tuberculous mycobacterial infection of the lung
2010
TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy
2019 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
The Science of Antibiotic Discovery
2020 Standout
Resurgence of tuberculosis in children
1992 Standout
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
2014
Mechanisms of Bacterial Resistance to Antibiotics and Biocides
1998
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Simultaneous Genotyping and Species Identification Using Hybridization Pattern Recognition Analysis of Generic Mycobacterium DNA Arrays
1998
Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS
1993
Bacterial resistance to antibiotics: Enzymatic degradation and modification
2005
Epidemiology of human pulmonary infection with mycobacteria nontuberculous
2002
Mycobacterium abscessus Pseudoinfection Traced to an Automated Endoscope Washer: Utility of Epidemiologic and Laboratory Investigation
1994
Performance of Candida Real-time Polymerase Chain Reaction, -D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis
2012
The Mycobacterium tuberculosis Virulence Factor Trehalose Dimycolate Imparts Desiccation Resistance to Model Mycobacterial Membranes
2008 StandoutNobel
Nontuberculous mycobacteria in the environment
2002
Infection with Mycobacterium malmoense in Sweden: Report of 221 Cases
1994
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
1993 Standout
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
2013
Disseminated Mycobacterium genavense Infection in Two Patients with AIDS
1994
A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens
2009
Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active Tuberculosis
2009
Leprosy
2004 Standout
A Riboswitch-Based Inducible Gene Expression System for Mycobacteria
2012 StandoutNobel
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages
2004 Standout
Mycobacterium simiaePseudo‐outbreak Resulting from a Contaminated Hospital Water Supply in Houston, Texas
2002
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Molecular Fingerprinting ofMycobacterium tuberculosis: How Can It Help the Clinician?
1997
Molecular detection, identification and drug resistance detection inMycobacterium tuberculosis: Table 1
2009
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Mycolic acids: structure, biosynthesis and physiological functions
1998
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay
1995
Ring-substituted quinolines as potential anti-tuberculosis agents
2004
High density synthetic oligonucleotide arrays
1999 Standout
The Impact of Nontuberculous Myobacteria on Management of Presumed Pulmonary Tuberculosis
2001
Pyrazinamide Sterilizing Activity In Vitro against Semidormant Mycobacterium tuberculosis Bacterial Populations
1992
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Early Manifestations of DisseminatedMycobacterium aviumComplex Disease: A Prospective Evaluation
1997
Efficacy of Rifabutin in the Treatment of Disseminated Infection Due to Mycobacterium avium Complex
1994
Adaptive immunity to SARS-CoV-2 and COVID-19
2021
Genome-Based Taxonomic Classification of the Phylum Actinobacteria
2018 Standout
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
2015
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
2007
The curious characteristics of pyrazinamide: a review.
2003
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
Microaerophilic Conditions Promote Growth of Mycobacterium genavense
1998
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Mycobacterium shinjukuense sp. nov., a slowly growing, non-chromogenic species isolated from human clinical specimens
2010
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
2011
Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
2009
Molecular Physiology of P2X Receptors
2002 Standout
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
1995
Transmission of a Highly Drug-Resistant Strain (Strain W1) of Mycobacterium tuberculosis
1997
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis
1993 Standout
Dihydropteroate Synthase of Mycobacterium leprae and Dapsone Resistance
2000
NOSOCOMIAL OUTBREAKS/PSEUDO OUTBREAKS CAUSED BY NONTUBERCULOUS MYCOBACTERIA
1998
Mycobacterium genavense infections in pet animals
1996
Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa
2015
Identification and subspecific differentiation of Mycobacterium scrofulaceum by automated sequencing of a region of the gene (hsp65) encoding a 65-kilodalton heat shock protein
1996
Synthesis and Electrochemistry of 2-Ethenyl and 2-Ethanyl Derivatives of 5-Nitroimidazole and Antimicrobial Activity against Giardia lamblia
2009 StandoutNobel
Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic
1991
Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens
2015
Multidrug Resistant Mycobacterium leprae from Patients with Leprosy
2001
In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis
2013
Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
2014
Invasive Candidiasis
2015 Standout
Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated Mycobacterium tuberculosis
2003
Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from India
2001
Osmosensory signaling in Mycobacterium tuberculosis mediated by a eukaryotic-like Ser/Thr protein kinase
2013 StandoutNobel
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Mycobacterium parmense sp. nov.
2004
Mycolic Acid Analysis by High-Performance Liquid Chromatography for Identification ofMycobacteriumSpecies
2001
Necrotizing fasciitis in a medical center in northern Taiwan: emergence of methicillin-resistant Staphylococcus aureus in the community.
2007
Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption
2008
Nonreplicating Persistence ofMycobacteriumTuberculosis
2001
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
The Crisis in Antibiotic Resistance
1992 StandoutScience
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
2007
ATP-Induced Killing of VirulentMycobacterium tuberculosisWithin Human Macrophages Requires Phospholipase D
2000
Disseminated Infection with Mycobacterium genavense : a Challenge to Physicians and Mycobacteriologists
1999
Epidemiology of infection by nontuberculous mycobacteria
1996
Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory
1993
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients
2012
Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s
2003
Mycobacterium florentinum sp. nov., isolated from humans
2005
Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa
2005
Mycobacterium celeriflavum sp. nov., a rapidly growing scotochromogenic bacterium isolated from clinical specimens
2014
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Separation among Species of Mycobacterium terrae Complex by Lipid Analyses: Comparison with Biochemical Tests and 16S rRNA Sequencing
1998
Design of Selective Substrates and Activity-Based Probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis
2016
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus
1996
Origins and Evolution of Antibiotic Resistance
2010 Standout
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
1997 Standout
PapA1 and PapA2 are acyltransferases essential for the biosynthesis of theMycobacterium tuberculosisvirulence factor Sulfolipid-1
2007 StandoutNobel
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
2007
Mycobacterium europaeum sp. nov., a scotochromogenic species related to the Mycobacterium simiae complex
2010
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Molecular Detection of Rifampin and Ofloxacin Resistance for Patients Who Experience Relapse of Multibacillary Leprosy
2002
Characterization of rpoB Mutations in Rifampin-Resistant Clinical Isolates of Mycobacterium tuberculosis from Turkey by DNA Sequencing and Line Probe Assay
2002
Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis
2002 Standout
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Simultaneous Detection of Mycobacterium leprae and Its Susceptibility to Dapsone Using DNA Heteroduplex Analysis
2001
The Continuing Challenges of Leprosy
2006 Standout
The Mycobacterium avium complex
1993
Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis
1993
Detection and Differentiation of Mycobacterium Avium and Mycobacterium Genavense by Polymerase Chain Reaction and Restriction Enzyme Digestion Analysis
2000
Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods
1995
Works of Max Salfinger being referenced
Rapid and Simple Approach for Identification of Mycobacterium tuberculosis Complex Isolates by PCR-Based Genomic Deletion Analysis
2002
Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin
2007
The new diagnostic mycobacteriology laboratory
1994
Pyrazinamide and Pyrazinoic Acid Activity against Tubercle Bacilli in Cultured Human Macrophages and in the BACTEC System
1990
Laboratory Diagnosis of Mycobacterial Infections: New Tools and Lessons Learned
2001
Mycobacterial identification by computer-aided gas-liquid chromatography
1994
Invasive infection withMycobacterium genavense in three children with the acquired immunodeficiency syndrome
1993
Epidemiology and Clinical Significance of Nontuberculous Mycobacteria in Patients Negative for Human Immunodeficiency Virus in Switzerland
1992
1,25(OH) 2 -Vitamin D 3 Synergizes with Pyrazinamide To Kill Tubercle Bacilli in Cultured Human Macrophages
1989
Laboratory diagnosis of nontuberculous mycobacteria
2002
Extrapulmonary and Disseminated Infections Due to Mycobacterium malmoense: Case Report and Review
1993
Extensively drug-resistant tuberculosis in a young child after travel to India
2015
Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis
2002
Evaluation of a Polymerase Chain Reaction–Based Universal Heteroduplex Generator Assay for Direct Detection of Rifampin Susceptibility ofMycobacterium tuberculosisfrom Sputum Specimens
1998
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
2001
Pseudoepidemic of Nontuberculous Mycobacteria due to a Contaminated Bronchoscope Cleaning Machine
1992
DRUG RESISTANCE IN TUBERCULOSIS
1997
Mycobacterium tuberculosis complex differentiation by genomic deletion patterns with multiplex polymerase chain reaction and melting analysis
2010
Selection of a Moxifloxacin Dose That Suppresses Drug Resistance inMycobacterium tuberculosis,by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling
2004
Use of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories
2000
Direct Comparison of the GenoType MTBC and Genomic Deletion Assays in Terms of Ability To Distinguish between Members of the Mycobacterium tuberculosis Complex in Clinical Isolates and in Clinical Specimens
2008
Comparison of two pretreatment methods for the detection of mycobacteria of BACTEC and Lowenstein-Jensen slants
1987
False-Positive Results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis Complex Assay
2000
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
2017
Evaluation of Mycology Laboratory Proficiency Testing
1999
Molecular Characterization of Rifampin-Resistant Isolates of Mycobacterium tuberculosis from Hungary by DNA Sequencing and the Line Probe Assay
2001
Multiple-Genome Comparison Reveals New Loci for Mycobacterium Species Identification
2010
A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov
1997
Use of Molecular Methods To Identify the Mycobacterium tuberculosis Complex (MTBC) and Other Mycobacterial Species and To Detect Rifampin Resistance in MTBC Isolates following Growth Detection with the BACTEC MGIT 960 System
2003
Multicenter Laboratory Validation of Susceptibility Testing of Mycobacterium tuberculosis against Classical Second-Line and Newer Antimicrobial Drugs by Using the Radiometric BACTEC 460 Technique and the Proportion Method with Solid Media
1999
Mycobacteriosis due to Mycobacterium genavense in six pet birds
1993
Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis
1994
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
2016
Moxalactam in nosocomial infections with Serratia marcescens
1985
Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method
1988
Use of Smear-Positive Samples To Assess the PCR-Based Genotype MTBDR Assay for Rapid, Direct Detection of the Mycobacterium tuberculosis Complex as Well as Its Resistance to Isoniazid and Rifampin
2006
Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens
1996
Comparison of three methods for recovery of Mycobacterium avium complex from blood specimens
1988
Characterization of rifampin-resistance in pathogenic mycobacteria
1994
[Mycobacterium malmoense infection of the flexor tendon sheath].
1992